of weakness of left side of the body for 12 hours. Prior to the weakness she has history of fall 4 days back followed by deviation of mouth to the right side & slurring of speech. There was no history of headache, vomiting, blurring of vision, convulsion or Loss of consciousness. Her bowel bladder function were intact. She had been in her usual state of health before this event. She is married for 4 years, Para-1+0; age of the last child was 1 and half year, on contraceptive pill (OCP) for the last 1 year, her menstrual cycle was regular, flow was average, menstrual period lasted 3-5 days. There was no positive family history for any thrombotic events. She was nonsmoker, nonalcoholic & no history of taking betel nuts. On examination: facial asymmetry, angle of mouth deviated to right, GCS -12/15; pulse was 70 beats/min, BP-110/70 mm Hg, respiratory rate-16/min, temp: 98.4°F, JVP was not raised. On nervous system examination we found, that higher psychic function was intact, patient was conscious, well alert, GCS 12/15, orientation with time, place & person was intact, her speech was slurred but memory was intact. There was no sign of meningeal irritation, upper motor neuron type facial palsy was seen; motor ESR-28 mm at 1st hour, platelet count-272000/mm3; LFT, S. electrolyte, renal function test& sugar profile and lipid profile were within normal limit. X-ray chest P/A view was-unremarkable & ECG revealed right axis deviation, MRI of brain showed acute infarct in right cerebral hemisphere (temporo-parietal region), Echocardiography was normal, good LV function (EF-68%), noregional wall hypokinesia was seen. VDRL test came non-reactive & Hepatitis B, C profile was negative. Then atypical causes of the stroke were investigated, which included: ANA-negative, Protein C-169 % (normal range 70-130%), MR angiogram: negative, Protein S-5% (normal range 60->130%) done 1 month after admission. She was initially treated with aspirin (75mg OD), atorvastatin (10mg OD) &vinpocetine (5mg); as patient developed gastrointestinal upset after starting aspirin it was then stopped. Later warfarin (2.5 mg OD) was added & patient responded well. On cardiovascular system examination: pulse was 74 beats /min, regular in rhythm, normal in volume, bilaterally symmetrical, no radio-radial & radiofemoral delay, all the peripheral pulses were palpable, apex beat was in left 5th intercostal space in midclavicular line & of no definite character; there was no palpable thrill, parasternal heave or epigastric pulsation; on auscultation: 1st & 2nd heart sounds were well audible & there was no murmur/added sound, there was no carotid bruit. Other systemic examination revealed nothing abnormality.
Case 2
Investigation reports revealed: CBC: TC of WBC-14500/mm3, DC of WBC-N-90 %, L-7%, Hbg/dL; ESR-28 mm at 1st hour,platelet count-272000/mm3; LFT, S. Electrolyte sugar profile, renal function test, lipid profile were within normal limit . X-ray chest P/A view & ECG were unremarkable, CT scan of brain showed microvascularischemia in left parietal region with cerebral oedema, Echocardiography: normal, good LV function(EF-61%), no regional wall hypokinesia. VDRLtest came non-reactive&hepatitis B, C profile was negative. Then atypical causes of the stroke were investigated , which included: ANA-negative, Antiphospholipid antibody (IgG&IgM)-negative, S. Homocysteine level-7.85 µmol/L(normal range 4.44-13.56)-normal; Protein C level was >150%, Protein S-<10%( normal range 60->130%) done on 5th day of admission . She was initially treated with ceftriaxone, atorvastatin (10mg OD) &vinpocetine (5mg). Later warfarin (2.5 mg OD) is added & patient responded well.
Discussion:
There are certain recognized stroke risk factors among which some are fixed like age, gender, heredity, previous vascular event and high fibrinogen level and some are modifiable like high blood pressure, heart disease (atrial fibrillation, heart failure, endocarditis), diabetes mellitus, hyperlipidemia, smoking, excess alcohol consumption, polycythemia, OCP, social deprivation, etc. 4 As age is among the risk factors, stroke is often thought to be a disease of the elderly, though in actuality it can happen in all ages from perinatal period to very old age. "Young stroke" may be defined as stroke at 44 years or less age 5 ). Each age group has characteristic causes, in the adolescence and early adult life, the list of causative factors includes 6-9 :
1. Pregnancy and puerperium According to Markus and Humbley, screening for lupus anticoagulant, anticardioplipid antibodies, deficiency of protein C, S, and antithrombin III is justified in unexplained strokes occurring in children and young adults, in families where members have had frequent strokes and pregnant or parturient women and women who are migraineurs or taking birth control pills (10) .Haematological factors indeed may play significant role in causation of thrombotic stroke. Deficiency of any one of the Protein C, Protein S or Antithrombin III may predispose to in-situ thrombosis within either the arterial or venous system and are a cause of otherwise unexplained strokes in young patients (10) .Carod-Artal, et. al. (11) found that prothrombotic conditions are more frequent among the young ischaemic stroke patients classified as strokes of undetermined cause(5). Interestingly they did find association of protein S desiciency with stroke of undetermined cause but they did not find any association between inherited thrombophilic disorders and any of the subtypes of ischaemic strokes among the older patients.
Protein S deficiency itself can be due to (3) In both of our cases we ruled out all other possible causative factors.
Conclusion
We believe that in both cases inherited Protein S deficiency which had been dormant previously, due to the effect of OCP or pregnancy, got more pronounced and to such a level as to culminate into arterial stroke.
To confirm the inherited nature of the condition, molecular study should be done to detect PROS 1 or PS-á mutation which is the Protein S encoding gene situated on the chromosome 3 near the centromere at 3q11.2(3) by PCR amplification followed by single strand conformation polymorphism or denaturing gradient gel electrophoresis analysis and DNA sequencing and particularly direct DNA sequencing (13) . DNA based assays are not affected by acute thrombotic event or use of anticoagulants or thrombolytic therapy hence can be performed at any time(14) (15) . Plasma based assays for these disorders should be repeated 3-6 months after the initial thrombotic episode to avoid false positive results and unnecessary prolonged anticoagulation therapy. The assays should be done at least 2 weeks after discontinuation of oral anticoagulation or heparin(14) (15) . Asymptomatic carriers are not recommended for anticoagulation but symptomatic carriers can be treated according to same routine as for venous thromboembolism (7) .Though anticoagulation should be avoided in the acute phase, to avoid the risk of haemorrhagic transformation.
